Invention Grant
- Patent Title: 18-20 member bi-polycyclic compounds
-
Application No.: US16502092Application Date: 2019-07-03
-
Publication No.: US10752591B2Publication Date: 2020-08-25
- Inventor: David Bettoun , Eduardo Martinez , James Gleason , Sylvie Mader , Shuo Xing
- Applicant: Haro Pharmaceutical Inc. , The Royal Institution for the Advancement of Learning/McGill University , Universite De Montreal
- Applicant Address: US PA Merion Station CA Montreal CA Montreal
- Assignee: Haro Pharmaceuticals Inc.,The Royal Institution for the Advancement of Learning/McGill University,Universite De Montreal
- Current Assignee: Haro Pharmaceuticals Inc.,The Royal Institution for the Advancement of Learning/McGill University,Universite De Montreal
- Current Assignee Address: US PA Merion Station CA Montreal CA Montreal
- Agency: A.C. Entis-IP Ltd.
- Agent Allan C. Entis; Kenichi N. Hartman
- Main IPC: C07D215/54
- IPC: C07D215/54 ; C07D215/48 ; C07D409/04 ; C07C259/10 ; C07D209/08 ; C07D209/42
Abstract:
The invention relates to a method of inhibiting loss of muscle mass or muscle function in a subject in need thereof, or a method of treating miofibers ex vivo, the method comprising administering a therapeutically effective amount of a 18-20 member bi-polycyclic compound to the subject or to the miofibers.
Public/Granted literature
- US20190389806A1 18-20 MEMBER BI-POLYCYCLIC COMPOUNDS Public/Granted day:2019-12-26
Information query
